Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04705948 |
Other study ID # |
UTEM POST |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 7, 2020 |
Est. completion date |
February 7, 2021 |
Study information
Verified date |
May 2021 |
Source |
University Tunis El Manar |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
A prospective randomized double-blind study including patients ASA I-II, aged more than 18
years undergoing surgery under general anesthesia (GA) and endotracheal intubation. Patients
were randomized allocated into 2 groups: ketamine group received ketamine gargle (0.5 mg/kg
up to 30 ml dextrose water) and magnesium group received magnesium sulfate gargle (20 mg/kg
up to 30 mL dextrose water ) 15 minutes before the operation.
Our primary outcome is sore throat and the secondary judging criteria are cough, dysphonia
and satisfaction. A standardized anesthesia protocol was followed for all patients. After
extubation, the patients were asked to grade POST, hoarseness, and cough at 15 min, 1h, and
24 h.
Description:
This is a prospective, single-center, randomized, double-blind study. the investigators
included in the study the patients:
whose age is greater than or equal to 18 years; ASA class 1 or 2, proposed for elective
visceral, orthopedic, oncology, ophthalmologic, urologic surgery under general anesthesia
with orothracheal intubation, expected duration ≤ 120 min.
the non-inclusion criteria are known allergy to ketamine or maguisuim sulphate, ASA 3 and
more, cervical surgery; rapid sequence induction, difficult intubation planned or history of
difficult intubation, malformation of the O.R.L sphere; upper respiratory tract infections.
the need for multiple laryngoscopies for orotracheal intubation (≥ 2 attempts); the need for
a postoperative nasogastric tube.
randomization is performed upon entering the operating room. The gargle allocation scheme,
Ketamine Group or Magnesium Sulfate Group was randomly generated using a randomization table
with an allocation ratio of 1: 1.
Postoperative follow-up was carried out in the post-intervention monitoring room then in
hospitalization within the various referring services (general surgery, orthopedics, O.R.L
and ophthalmology).
On the day of the procedure, the doctor responsible for the study prepares the two types of
solutions containing:
- One of magnesium sulfate (20mg / kg diluted in 30cc of 5% glucose serum);
- The other ketamine (50mg diluted in 30cc of 5% glucose serum). These two solutions were
distributed over two groups of patients for use as a gargle, lasting at least 60 seconds
for each patient in each group and 15 minutes before the surgery.
The primary endpoint is the incidence and severity of POST at the twenty-fourth hour
postoperatively The secondary outcomes are the incidence and severity of POST at 15 minutes
and one hour postoperatively; The occurrence of cough, The presence of dysphonia and Patient
satisfaction
The severity of POST was scored on a three-point score from 0 to 2 (0 = No pain; 1 =
Oropharyngeal pain on speaking; 2 = Spontaneous oropharyngeal pain)